Matches in SemOpenAlex for { <https://semopenalex.org/work/W1952508559> ?p ?o ?g. }
- W1952508559 endingPage "djv197" @default.
- W1952508559 startingPage "djv197" @default.
- W1952508559 abstract "The radiotherapy or ibandronate (RIB) trial was a randomized multicenter nonblind two-arm trial to compare intravenous ibandronate given as a single infusion with single-dose radiotherapy for metastatic bone pain. Four hundred seventy prostate cancer patients with metastatic bone pain who were suitable for local radiotherapy were randomly assigned to radiotherapy (single dose, 8 Gy) or intravenous infusion of ibandronate (6mg) in a noninferiority trial. Pain was measured using the Brief Pain Inventory at baseline and four, eight, 12, 26, and 52 weeks. Pain response was assessed using World Health Organization (WHO) criteria and the Effective Analgesic Score (EAS); the maximum allowable difference was ±15%. Patients failing to respond at four weeks were offered retreatment with the alternative treatment. Quality of life (QoL) was assessed at baseline and four and 12 weeks. Because the trial was designed with a 5% one-sided test, we provide 90% confidence intervals (two-sided) for differences in pain response. Overall, pain response was not statistically different at four or 12 weeks (WHO: −3.7%, 90% confidence interval [CI] = −12.4% to 5.0%; and 6.7%, 90% CI = −2.6 to 16.0%, respectively). Corresponding differences using the EAS were −7.5% and −3.5%. However, a more rapid initial response with radiotherapy was observed. There was no overall difference in toxicity, although each treatment had different side effects. QoL was similar at four and 12 weeks. Overall survival was similar between the two groups but was better among patients having retreatment than those who did not. A single infusion of ibandronate had outcomes similar to a single dose of radiotherapy for metastatic prostate bone pain. Ibandronate could be considered when radiotherapy is not available." @default.
- W1952508559 created "2016-06-24" @default.
- W1952508559 creator A5018708168 @default.
- W1952508559 creator A5019646420 @default.
- W1952508559 creator A5020453607 @default.
- W1952508559 creator A5024289503 @default.
- W1952508559 creator A5039700176 @default.
- W1952508559 creator A5048633799 @default.
- W1952508559 creator A5050265583 @default.
- W1952508559 creator A5051287771 @default.
- W1952508559 creator A5054720614 @default.
- W1952508559 creator A5079389438 @default.
- W1952508559 creator A5079843750 @default.
- W1952508559 creator A5083120377 @default.
- W1952508559 creator A5086095759 @default.
- W1952508559 date "2015-08-04" @default.
- W1952508559 modified "2023-10-13" @default.
- W1952508559 title "A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer" @default.
- W1952508559 cites W1991788040 @default.
- W1952508559 cites W1992625706 @default.
- W1952508559 cites W2003949207 @default.
- W1952508559 cites W2009700462 @default.
- W1952508559 cites W2011155558 @default.
- W1952508559 cites W2011398881 @default.
- W1952508559 cites W2017845136 @default.
- W1952508559 cites W2019630239 @default.
- W1952508559 cites W2022098162 @default.
- W1952508559 cites W2027735110 @default.
- W1952508559 cites W2052544640 @default.
- W1952508559 cites W2053787128 @default.
- W1952508559 cites W2113235727 @default.
- W1952508559 cites W2114046986 @default.
- W1952508559 cites W2135535385 @default.
- W1952508559 cites W2138156952 @default.
- W1952508559 cites W2168973553 @default.
- W1952508559 doi "https://doi.org/10.1093/jnci/djv197" @default.
- W1952508559 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26242893" @default.
- W1952508559 hasPublicationYear "2015" @default.
- W1952508559 type Work @default.
- W1952508559 sameAs 1952508559 @default.
- W1952508559 citedByCount "28" @default.
- W1952508559 countsByYear W19525085592014 @default.
- W1952508559 countsByYear W19525085592015 @default.
- W1952508559 countsByYear W19525085592016 @default.
- W1952508559 countsByYear W19525085592017 @default.
- W1952508559 countsByYear W19525085592018 @default.
- W1952508559 countsByYear W19525085592019 @default.
- W1952508559 countsByYear W19525085592020 @default.
- W1952508559 countsByYear W19525085592021 @default.
- W1952508559 countsByYear W19525085592022 @default.
- W1952508559 countsByYear W19525085592023 @default.
- W1952508559 crossrefType "journal-article" @default.
- W1952508559 hasAuthorship W1952508559A5018708168 @default.
- W1952508559 hasAuthorship W1952508559A5019646420 @default.
- W1952508559 hasAuthorship W1952508559A5020453607 @default.
- W1952508559 hasAuthorship W1952508559A5024289503 @default.
- W1952508559 hasAuthorship W1952508559A5039700176 @default.
- W1952508559 hasAuthorship W1952508559A5048633799 @default.
- W1952508559 hasAuthorship W1952508559A5050265583 @default.
- W1952508559 hasAuthorship W1952508559A5051287771 @default.
- W1952508559 hasAuthorship W1952508559A5054720614 @default.
- W1952508559 hasAuthorship W1952508559A5079389438 @default.
- W1952508559 hasAuthorship W1952508559A5079843750 @default.
- W1952508559 hasAuthorship W1952508559A5083120377 @default.
- W1952508559 hasAuthorship W1952508559A5086095759 @default.
- W1952508559 hasBestOaLocation W19525085591 @default.
- W1952508559 hasConcept C121608353 @default.
- W1952508559 hasConcept C126322002 @default.
- W1952508559 hasConcept C141071460 @default.
- W1952508559 hasConcept C159110408 @default.
- W1952508559 hasConcept C168563851 @default.
- W1952508559 hasConcept C2776139714 @default.
- W1952508559 hasConcept C2777783956 @default.
- W1952508559 hasConcept C2779951463 @default.
- W1952508559 hasConcept C2780192828 @default.
- W1952508559 hasConcept C2780820201 @default.
- W1952508559 hasConcept C42219234 @default.
- W1952508559 hasConcept C44249647 @default.
- W1952508559 hasConcept C509974204 @default.
- W1952508559 hasConcept C535046627 @default.
- W1952508559 hasConcept C71924100 @default.
- W1952508559 hasConceptScore W1952508559C121608353 @default.
- W1952508559 hasConceptScore W1952508559C126322002 @default.
- W1952508559 hasConceptScore W1952508559C141071460 @default.
- W1952508559 hasConceptScore W1952508559C159110408 @default.
- W1952508559 hasConceptScore W1952508559C168563851 @default.
- W1952508559 hasConceptScore W1952508559C2776139714 @default.
- W1952508559 hasConceptScore W1952508559C2777783956 @default.
- W1952508559 hasConceptScore W1952508559C2779951463 @default.
- W1952508559 hasConceptScore W1952508559C2780192828 @default.
- W1952508559 hasConceptScore W1952508559C2780820201 @default.
- W1952508559 hasConceptScore W1952508559C42219234 @default.
- W1952508559 hasConceptScore W1952508559C44249647 @default.
- W1952508559 hasConceptScore W1952508559C509974204 @default.
- W1952508559 hasConceptScore W1952508559C535046627 @default.
- W1952508559 hasConceptScore W1952508559C71924100 @default.
- W1952508559 hasIssue "10" @default.
- W1952508559 hasLocation W19525085591 @default.